CEO Punjab Saaf Pani Authority, Capt. (R) Syed Ali Asghar, visited the Punjab Agriculture, Food and Drug Authority (PAFDA) to review its laboratory capabilities and explore avenues for coordination in water quality testing and monitoring systems. The visit provided an overview of PAFDA’s advanced analytical infrastructure and its role in ensuring quality and safety across multiple sectors, including water testing for public health protection.

During the visit, discussions focused on strengthening collaboration between both institutions to enhance water quality assessment, improve monitoring mechanisms, and support evidence-based decision-making. The engagement highlighted the importance of integrated scientific systems in ensuring safe drinking water and reinforced a shared commitment to safeguarding public health through reliable testing and regulatory frameworks.

Secretary Home Department Punjab, Dr. Ahmed Javed Qazi, visited the Punjab Agriculture, Food and Drug Authority (PAFDA) to review its operational systems, laboratory infrastructure, and ongoing initiatives. The visit provided an overview of PAFDA’s integrated approach to testing and regulation across food, agriculture, and pharmaceutical sectors, highlighting its role in ensuring quality, safety, and compliance through advanced scientific systems.

During the visit, discussions focused on strengthening operational efficiency, enhancing inter-departmental coordination, and aligning future priorities with emerging regulatory and public service needs. The review underscored PAFDA’s continued evolution as a modern, science-driven institution committed to delivering reliable, evidence-based outcomes and reinforcing public confidence in regulatory systems across Punjab.

Following the formalization of an Agreement of Cooperation (AoC), PAFDA, in collaboration with CABI, organized a workshop aimed at advancing shared priority areas for the coming year. The session was designed to operationalize the partnership by translating strategic objectives into practical initiatives, with a focus on strengthening research, knowledge access, and scientific capacity.

The workshop provided scientists with exposure to CABI’s global resources and access to specialized training materials, enabling them to explore tools and methodologies relevant to their work. Through this interactive session, participants engaged with learning platforms and gained insights to support evidence-based practices. The initiative marks an important step in implementing the AoC and reinforcing a structured approach to collaboration, capacity building, and innovation.

PAFDA hosted Prof. Dr. Munir Iqbal, Head of the Avian Influenza and Newcastle Disease Group at The Pirbright Institute, UK, a leading international research institute in animal health and disease control. The visit provided an opportunity to engage with global expertise in critical areas of animal and public health, particularly in the context of emerging and zoonotic diseases.

During the engagement, discussions focused on potential collaboration in disease research, diagnostics, and laboratory systems. Both sides emphasized the importance of knowledge exchange and scientific cooperation to strengthen surveillance, improve response mechanisms, and support overall health security. The visit reflects PAFDA’s commitment to building international partnerships that advance research, innovation, and public health outcomes.

PAFDA formalized an Agreement of Cooperation (AoC) with the Global Alliance for Improved Nutrition (GAIN) to strengthen collaborative efforts in improving food systems and nutritional outcomes in Pakistan. The ceremony was attended by Ms. Farrah Naz, Country Director, and Mr. Adil Daniel, Project Manager at GAIN, marking the beginning of a strategic partnership focused on public health and nutrition.

The collaboration aims to promote awareness, enhance food quality standards, and support evidence-based initiatives to address nutritional challenges. By combining expertise and resources, both organizations seek to advance sustainable solutions that contribute to improved health outcomes and a stronger, more resilient food system in Pakistan.

PAFDA welcomed Mr. Mohammad Muggo (CEO, United Industries Ltd / United Snacks Ltd), Mr. Muhammad Shahnawaz (Director HR & Public Affairs, United Industries Ltd), and Dr. Umair Bajwa (Director Industrial Linkages, GCUF) for a visit aimed at strengthening collaboration between industry and academia. The engagement focused on understanding industry needs, promoting knowledge exchange, and aligning efforts towards improved quality standards and regulatory practices.

During the visit, the delegation toured PAFDA’s laboratories and appreciated its advanced testing infrastructure and capabilities. Discussions highlighted opportunities for enhanced cooperation in testing services, compliance support, and innovation-driven practices. The visit reflects PAFDA’s commitment to fostering strong partnerships that contribute to a more efficient, quality-focused, and competitive ecosystem.

PAFDA welcomed a 3-member delegation from Wilson’s Pharma Group, comprising Mr. M. Kashif Mirza (Group Director Technical Operations), Dr. M. Zahid Yusuf (Head of Business Development), and Mr. Masood Ahmed (Deputy GM Quality Control). The visit was aimed at exploring opportunities for collaboration in quality assurance, testing systems, and regulatory alignment within the pharmaceutical sector.

During the visit, the delegation toured PAFDA’s laboratories to observe its advanced testing infrastructure and operational capabilities. Discussions focused on strengthening cooperation in ensuring high-quality standards, enhancing compliance mechanisms, and supporting industry through reliable and efficient testing services. The engagement reflects PAFDA’s commitment to fostering partnerships that contribute to a more robust and quality-driven pharmaceutical ecosystem.

PAFDA welcomed H.E. Ladislav Steinhübel, Ambassador of the Czech Republic to Pakistan, along with distinguished guests, for a visit aimed at strengthening international collaboration. The engagement provided an opportunity to showcase PAFDA’s infrastructure, testing capabilities, and integrated approach towards ensuring quality and safety across food, agriculture, and pharmaceutical sectors.

During the visit, discussions focused on exploring avenues for cooperation in research, laboratory systems, and knowledge exchange. Both sides emphasized the importance of collaborative efforts in advancing regulatory frameworks, improving testing standards, and fostering innovation. The visit reflects PAFDA’s commitment to building global partnerships that contribute to enhanced quality assurance and public health outcomes.

A delegation from Air Pharmaceuticals, led by CEO Prof. Dr. Humayun Riaz, visited the Punjab Agriculture, Food and Drug Authority (PAFDA) to explore avenues for collaboration in the pharmaceutical sector. The visit focused on strengthening linkages between industry and regulatory frameworks, with an emphasis on quality assurance, testing standards, and compliance mechanisms.

During the engagement, both sides discussed opportunities to enhance cooperation in laboratory support, regulatory facilitation, and innovation-driven practices. The visit reflects PAFDA’s commitment to working closely with industry stakeholders to promote high-quality pharmaceutical standards, ensure public safety, and support a more robust and compliant healthcare ecosystem in Pakistan.

The Punjab Agriculture, Food and Drug Authority (PAFDA) welcomed a delegation from The Searle Company Limited, led by Mr. Tahir Ahmad, Chief Executive Officer, for a visit to its laboratory facilities. The visit reflects the growing importance of collaboration between regulatory authorities and the pharmaceutical industry to ensure quality, safety, and compliance across healthcare systems.

During the visit, the delegation was given a comprehensive overview of PAFDA’s advanced testing systems and analytical capabilities. Discussions focused on strengthening cooperation in areas of pharmaceutical testing, quality assurance, and regulatory alignment. The engagement highlighted a shared commitment to supporting safe, effective, and high-quality healthcare products, while reinforcing systems that contribute to public health protection and industry confidence.